跳至主要内容
临床试验/NCT05060861
NCT05060861Unknown不适用

Safety, Efficacy and Immunogenicity of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

Assiut University1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,000
试验地点
1
主要终点
To evaluate the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis

研究概览

简要总结

Since the beginning of COVID-19 pandemic, a safe and effective vaccine against infection and development of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed control of the wide spread of COVID-19 and reduce death rates throughout the world. Many clinical trials investigated the immunogenicity of different proposed vaccine including the first distributed vaccine; the ChAdOx1 nCoV-19 vaccine and there is a need to analyze the results of published clinical trials.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant who received 2 doses of ChAdOx1 nCoV-19 vaccine

排除标准

  • non vaccinated person

结局指标

主要结局

To evaluate the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis

时间窗: up to one year

the frequency of breakthrough COVID-19 infection

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aliae AR Mohamed Hussein

Professor of Pulmonology

Assiut University

研究点 (1)

Loading locations...

相似试验